BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21718594)

  • 81. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
    Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
    Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Independent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma.
    Jiang D; Song Q; Wang H; Huang J; Wang H; Hou J; Li X; Xu Y; Sujie A; Zeng H; Tan L; Hou Y
    Oncotarget; 2017 Jan; 8(5):8315-8329. PubMed ID: 28039448
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.
    Harris BN; Bhuskute AA; Rao S; Farwell DG; Bewley AF
    Head Neck; 2016 Sep; 38(9):1380-6. PubMed ID: 27014858
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.
    Ren Y; Su C; Zhou Y; Zhao X; Yang CL; Liu YY
    World J Gastroenterol; 2014 Dec; 20(47):17970-5. PubMed ID: 25548496
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Clinical significance of HAX-1 expression in laryngeal carcinoma.
    You Y; Yao H; You B; Li X; Ni H; Shi S; Shan Y; Cao X
    Auris Nasus Larynx; 2015 Aug; 42(4):299-304. PubMed ID: 25554539
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery.
    MacKenzie RG; Franssen E; Balogh JM; Gilbert RW; Birt D; Davidson J
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):65-71. PubMed ID: 10758306
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Correlation of cervical lymphatic metastasis to prognosis of glottic carcinoma: a report of 333 cases].
    Zhang Q; Lai FY; Guo ZM; Zeng ZY; Song M; Yu WB; Yang CS
    Ai Zheng; 2007 Oct; 26(10):1138-42. PubMed ID: 17927888
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Prophylactic irradiation of cervical lymph nodes for Stage-N0 nasopharyngeal carcinoma].
    Xie FY; Peng M; Hu WH; Han F; Wang X; Xu HM
    Chin J Cancer; 2010 Jan; 29(1):106-10. PubMed ID: 20038321
    [TBL] [Abstract][Full Text] [Related]  

  • 89. T1 squamous cell carcinoma of the glottis with anterior commissure involvement: Radiotherapy versus transoral laser microsurgery.
    Alkan U; Nachalon Y; Shkedy Y; Yaniv D; Shvero J; Popovtzer A
    Head Neck; 2017 Jun; 39(6):1101-1105. PubMed ID: 28371063
    [TBL] [Abstract][Full Text] [Related]  

  • 90. T1 squamous cell carcinoma of the arytenoid.
    Laccourreye O; Weinstein G; Chabardes E; Housset M; Laccourreye H; Brasnu D
    Laryngoscope; 1992 Aug; 102(8):896-900. PubMed ID: 1495355
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The prognostic value of hemoglobin concentration in postoperative radiotherapy of 835 patients with laryngeal cancer.
    Rutkowski T; Suwinski R; Idasiak A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1018-23. PubMed ID: 17716825
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Postoperative irradiation in patients with pT3-4N0 laryngeal cancer: results and prognostic factors.
    Skóra T; Nowak-Sadzikowska J; Mucha-Małecka A; Szyszka-Charewicz B; Jakubowicz J; Gliński B
    Eur Arch Otorhinolaryngol; 2015 Mar; 272(3):673-9. PubMed ID: 25432639
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Radiation therapy for stage I and II laryngeal cancer using 10 MV X-rays or cobalt-60 gamma-rays.
    Hayakawa K; Mitsuhashi N; Tamaki Y; Takahashi M; Honjo J; Kamei T; Koyama I; Niibe H
    Radiat Med; 1992; 10(5):199-205. PubMed ID: 1438927
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Results of radiation therapy in carcinoma of the larynx.
    Skołyszewski J; Reinfuss M; Kowalska T
    Acta Radiol Oncol; 1984; 23(6):415-20. PubMed ID: 6099032
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Elective lateral neck dissection for laryngeal cancer in the clinically negative neck.
    Zhang B; Xu ZG; Tang PZ
    J Surg Oncol; 2006 May; 93(6):464-7. PubMed ID: 16615158
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
    Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
    Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Total laryngectomy and postoperative radiotherapy for T4 laryngeal cancer: a 14-year review.
    Ampil FL; Nathan CO; Caldito G; Lian TF; Aarstad RF; Krishnamsetty RM
    Am J Otolaryngol; 2004; 25(2):88-93. PubMed ID: 14976652
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Survivin expression in laryngeal squamous cell carcinoma and its relationship with clinical factors].
    Chen YF; Chen FJ; Fang Y; Yang AK; Zhang Q; Wu GH
    Ai Zheng; 2004 Nov; 23(11 Suppl):1493-7. PubMed ID: 15566665
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The prognostic role of radiotherapy and radiotherapy target in cervical lymph node metastatic squamous cell carcinoma with unknown primary: a retrospective study.
    Li R; Liao K; Wei Z; Liu Z; He Y; Wang J; He L; Mu X; Yang L; Huang Y; He L; Peng X
    J Cancer Res Clin Oncol; 2022 Jun; 148(6):1437-1445. PubMed ID: 34245371
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma.
    Dionysopoulos D; Pavlakis K; Kotoula V; Fountzilas E; Markou K; Karasmanis I; Angouridakis N; Nikolaou A; Kalogeras KT; Fountzilas G
    Strahlenther Onkol; 2013 Mar; 189(3):202-14. PubMed ID: 23400686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.